Related references
Note: Only part of the references are listed.A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An Infectious cDNA Clone of SARS-CoV-2
Xuping Xie et al.
CELL HOST & MICROBE (2020)
The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?
Julia L. McKechnie et al.
CELL HOST & MICROBE (2020)
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Li Guo et al.
CLINICAL INFECTIOUS DISEASES (2020)
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ling Ni et al.
IMMUNITY (2020)
Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status
Chih-Cheng Lai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Virological assessment of hospitalized patients with COVID-2019
Roman Woelfel et al.
NATURE (2020)
Low prevalence of active COVID-19 in Slovenia: a nationwide population study of a probability-based sample
P. Maver Vodicar et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
Christian Karagiannidis et al.
LANCET RESPIRATORY MEDICINE (2020)
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors
Pierre Gallian et al.
ANTIVIRAL RESEARCH (2020)
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
Marina Pollan et al.
LANCET (2020)
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Julian Braun et al.
NATURE (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Ann M. Arvin et al.
NATURE (2020)
Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands
Bas B. Oude Munnink et al.
NATURE MEDICINE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
The socio-economic implications of the coronavirus pandemic (COVID-19): A review
Maria Nicola et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients
Larry L. Luchsinger et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19
Kumaragurubaran Karthik et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients
Yuxin Chen et al.
PLOS PATHOGENS (2020)
Convalescent plasma anti SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization
Eric Salazar et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effects of endocytosis inhibitors on internalization of human IgG by Caco-2 human intestinal epithelial cells
Koya Sato et al.
LIFE SCIENCES (2009)
Share Paper
